NCT03712774Recruiting
Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer
Source: ClinicalTrials.gov · Last updated 19 Oct 2018 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Prospective observational study to evaluate the Quality of life based on standardized EORTC questionaires as well as toxicities, functional and oncological outcomes in patients treated with neoadjuvant or definitive chemoradiation for esophageal Cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 17 Oct 2018
- Start date
- 12 Oct 2018
- Primary completion date
- 31 Dec 2021
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT03712774
What you commit to
- Study type: Observational
- Planned participants: 60
- From 12 Oct 2018 to the primary completion date, 31 Dec 2021
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with palliative intent
- Prior systemic treatment for esophageal Cancer
Other illness
- second malignancy
Age
- age \< 18 years
Other
- distant metastases (except supraclavicular nodes)
- Treatment in an interventional study
Who the study is looking for
- histologically proven esophageal Cancer (SCC or adenocarcinoma) without distant metastases (except supraclavicular nodes)
- indication for neoadjuvant or definitive chemoradiation using either cisplatin/5-FU or carboplatin/paclitaxel with curative intent
- age \>= 18 years
- written informed consent
- ability to answer the standardized questionaires according to the treating physician
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Radiation Oncology, University Hospital, LMU Munich Coordinator of this site? Confirm its status | Munich | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.